000 01255 a2200337 4500
005 20250512032809.0
264 0 _c19881214
008 198812s 0 0 eng d
022 _a0277-5379
024 7 _a10.1016/0277-5379(88)90221-0
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSchroyens, W A
245 0 0 _aComparative effect of cisplatin, spiroplatin, carboplatin, iproplatin and JM40 in a human myeloid clonogenic assay.
_h[electronic resource]
260 _bEuropean journal of cancer & clinical oncology
_cAug 1988
300 _a1309-12 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article
650 0 4 _aAntineoplastic Agents
_xtoxicity
650 0 4 _aBone Marrow
_xdrug effects
650 0 4 _aCarboplatin
650 0 4 _aCisplatin
_xtoxicity
650 0 4 _aColony-Forming Units Assay
650 0 4 _aEvaluation Studies as Topic
650 0 4 _aHumans
650 0 4 _aOrganoplatinum Compounds
_xtoxicity
700 1 _aMeeker, J B
700 1 _aDodion, P
700 1 _aStryckmans, P A
700 1 _aRozencweig, M
773 0 _tEuropean journal of cancer & clinical oncology
_gvol. 24
_gno. 8
_gp. 1309-12
856 4 0 _uhttps://doi.org/10.1016/0277-5379(88)90221-0
_zAvailable from publisher's website
999 _c3059019
_d3059019